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Placebo Science: Research You Can Believe In
Controversial and ethically tenuous, placebos are central to medicine.  Scientific reports make 
it clear, even if strange and counterintuitive, that receiving —unrelated to the actual content 
of — medical treatment can trigger and propel a healing process.  Thus, therapeutic effects 
can arise from knowledge that therapy is occurring, rather than from the direct physiologi-
cal effects of a drug or treatment, because expectations can result in physiological responses. 
Historically, fewer biochemically-viable therapies were available and healing practices in-
volved the widespread use of placebo treatments.  This practice fell out of favour, however, as 
better drugs and knowledge became part of the modern clinical armamentarium, and as a 
medical revolution shaped new professional codes and as ethics guidelines began to empha-
size patient autonomy. 
Placebos are a great vehicle to elucidate mind–body regulation.  Just a few weeks ago, on 
May 16th, the Royal Society — the world’s oldest scientific academy — published a volume of 
its Philosophical Transactions devoted to placebos.  In this regard, MBR is in good company. 
We dedicate the present and upcoming issues to placebo effects and placebo responses, and 
some of the data that bear on these elusive clinical and research themes.
Placebo effects are strongest for disorders that are predominantly mental and subjective. 
In the case of depression, for example, giving patients placebos can produce nearly the same 
effect as dosing them with the latest antidepressant drugs.  Pain is another area susceptible 
to placebo treatment: even when giving a placebo, leading patients to think that they are re-
ceiving morphine provides more pain relief than if they think that they are getting aspirin. 
Placebo treatments, moreover, can influence autonomic functions, including heartbeat and 
blood pressure.  The science of placebos poses some difficult questions: Why are placebo 
injections more effective than placebo pills?  And why is sham surgery more effective than 
both?  Why do red placebos stimulate whereas blue placebos calm?  Why do more placebos 
work better than few?  And why do more expensive placebos work better than cheaper ones? 
Symbolic thinking seems central to sketching even the most tentative answers.
Many physicians worry that for placebos to work deception is necessary.  And yet, at least 
in specific clinical contexts, placebos may effectuate strong therapeutic outcomes even if pa-
tients know that they are getting placebo treatments.
…In the medical clinic
Physicians use placebos.  That’s a fact.  Some people are comfortable with this fact.  Other in-
dividuals consider this trend a harmless form of duplicity or a virtuous lie.  Still others view it 
as downright unethical.  The American Medical Association (AMA) issued this stern warn-
ing in 2006: “Physicians may use [a] placebo for diagnosis or treatment only if the patient is 
informed of and agrees to its use.”  The AMA ruling followed a controversial article published 
by two Danish scientists in the New England Journal of Medicine, which concluded that “out-
side the setting of clinical trials, there is no justification for the use of placebos.”  Although 
this objectionable report has been widely critiqued and largely dismissed, many a practitioner 
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still tacitly endorses its tenor and undercurrents.  Whereas the AMA still adheres to the 
policy which largely frowns on the use of placebos in clinical practice, the German Medical 
Association recently announced considerable latitude in the clinical administration of place-
bos.  Canada, to date, has no formal policy on the use of placebos in the clinic.
My team as well as other research groups have probed the knowledge, practices, and 
beliefs of physicians concerning placebos.  We have canvassed randomly selected groups of 
doctors, both in Canada and the Unites States, who most often deal with conditions, such 
as depression, that respond well to placebos.  Findings from the United States, for example, 
show that more than half said they prescribed “placebo treatments” from time to time and 
that they believed the practice was ethical.  Some 40% said they used painkillers or vitamins 
as placebos and 13% acknowledged using antibiotics and sedatives for this purpose.  Barely 
3% said they use sugar pills.  Over two-thirds reported that they described the medicines to 
patients not as placebos, but euphemistically as “a potentially beneficial medicine or treat-
ment not typically used for their condition.”
A string of recent studies has drawn on imaging of the living human brain to show what 
areas light up as a result of placebo administration.  Though details are still preliminary, the 
patient’s “positive expectation of a reward” seems to play a major role in placebo effects and 
placebo responses.  The use of placebos often leads to the secretion of dopamine in the brains 
of people with Parkinson’s disease or to the release of endogenous painkillers in individuals 
suffering from pain.
Hidden dosing techniques demonstrate the power of the placebo effect.  In these open–
hidden paradigms, often used to research pain, we often administer morphine secretly, 
openly, or give a placebo masquerading as a powerful pain reliever.  Telling patients that 
they are receiving a painkiller, even when the injection is actually a saline solution, can be 
as potent as covertly administering 6–8mg of morphine — a level slightly below the standard 
post-operative dose of 10–12mg — with the covert dose needing to reach 12mg to surpass the 
placebo effect.  Giving pretend painkillers, therefore, can reduce the amount of pain a patient 
experiences.  On the other hand, patients taking fake opiates after having been prescribed 
the real thing may experience the shallow breathing that is a side-effect of the real drugs.
Whether a placebo is a way of placating a fretful patient or a legitimate exercise in mod-
ern therapeutics, the ethics of placebos is tenuous and the controversy over the use of place-
bos in the clinic is unlikely to disappear soon.
In clinical psychology
The history of psychological curative techniques — from the King’s Touch to the therapeutic 
spinning chair proposed by Erasmus Darwin and the theories of Sigmund Freud — reeks 
of placebo effects.  Harvard psychologist Saul Rosenzweig noted that all these healers and 
treatments had a similar way of working on the minds of patients: they used drama and 
ritual to divine a cure.  If that approach worked for thousands of years of human history, 
said Rosenzweig, why should contemporary mind-based therapies be different?  In 1936, 
Rosenzweig proposed an overarching recipe for any treatment, citing parameters such as the 
therapeutic alliance — the collaborative bond between the patient and therapist; the provi-
sion of a believable framework that placates potential distress; and the buoying hope patients 
experience once in therapy.  
Reporting an extremely strong bond with a therapist is hardly a guarantee to improvement. 
On the one hand, some practitioners seem to achieve considerably better results than their 
colleagues.  On the other hand, few studies have examined how the skills of a given therapist 
affect the outcome of treatment.  Findings from one such study, for example, suggest that the 
better therapists weren’t the ones who had more experience but those who would rather talk 
to their patients than prescribe medication and who expected talk-therapy to take a long time. 
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We should probably look for simple ways to make therapies work better.  Specific factors 
that have little to do with the theoretical foundation of a treatment could make a substantial 
difference.  For example, the ability to form a strong bond with clients and the manner one 
communicates with patients would both affect the outcome of many, if not any, intervention. 
Placebos are tricky, topical, and counterintuitive.  They work irrespective of our theoretical 
perspective and findings suggest that many a treatment could boost in effectiveness by en-
hancing the placebo impact.
In complementary and alternative medicine
Alternative medicine is big business.  Because the field is largely unregulated, reliable statis-
tics are hard to provide.  A conservative estimate, however, values the industry around the 
world at about $60 billion.
The rigorous study of everything from acupuncture and crystal healing to Reiki channel-
ling and herbal remedies reveals that around 95% of the treatments are statistically indistin-
guishable from placebo treatments.  In only 5% of cases was there either a clear benefit above 
and beyond a placebo or even just a hint that would warrant further research.
And yet research and education about the science of placebos helps address a serious 
public-health problem.  Research findings need to demonstrate that conventional medicines 
are both safe and efficacious before they can go on the market.  Alternative treatments, on 
the other hand, largely reassure consumers by appealing to a mixture of tradition and natu-
ral products.  While most claims are usually harmless, some can become dangerous (e.g., 
when practitioners, despite a lack of evidence, suggest that treatments, such as homeopathic 
remedies to cure malaria, work).
Unlike their conventional counterparts, practitioners of alternative medicine often excel 
at harnessing the placebo effect.  Whereas harried modern doctors struggle to find time, 
less conventional practitioners often offer long, relaxed consultations.  And these practition-
ers often believe passionately in their treatments, which often involve great and reassuring 
theatrics.  These meaningful flairs are enough to do some good, even though the magnets 
and crystals, by themselves, are likely meaningless.  
I hope the information you will find in the present, as well as the upcoming, issue of MBR 
will pique your curiosity and whet your appetite for placebos.
